BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22372375)

  • 1. NMR studies of the interaction between human programmed cell death 5 and human p53.
    Yao H; Feng Y; Zhou T; Wang J; Wang ZX
    Biochemistry; 2012 Apr; 51(13):2684-93. PubMed ID: 22372375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function correlation of human programmed cell death 5 protein.
    Yao H; Xu L; Feng Y; Liu D; Chen Y; Wang J
    Arch Biochem Biophys; 2009 Jun; 486(2):141-9. PubMed ID: 19358820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal 26-residue fragment of human programmed cell death 5 protein can form a stable alpha-helix having unique electrostatic potential character.
    Liu D; Yao H; Chen Y; Feng Y; Chen Y; Wang J
    Biochem J; 2005 Nov; 392(Pt 1):47-54. PubMed ID: 16083422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human programmed cell death 5 protein has a helical-core and two dissociated structural regions.
    Liu D; Feng Y; Cheng Y; Wang J
    Biochem Biophys Res Commun; 2004 May; 318(2):391-6. PubMed ID: 15120613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR.
    Petros AM; Gunasekera A; Xu N; Olejniczak ET; Fesik SW
    FEBS Lett; 2004 Feb; 559(1-3):171-4. PubMed ID: 14960327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
    Xu H; Tai J; Ye H; Kang CB; Yoon HS
    Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDCD5 functions as a regulator of p53 dynamics in the DNA damage response.
    Zhuge C; Sun X; Chen Y; Lei J
    J Theor Biol; 2016 Jan; 388():1-10. PubMed ID: 26433055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of binding constant and binding region of programmed cell death 5-heparin by capillary zone electrophoresis.
    Yi L; Xiaomei L; Hui F; Yingcheng Z; Dan L; Ying W
    J Chromatogr A; 2007 Mar; 1143(1-2):284-7. PubMed ID: 17257606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDCD5 interacts with p53 and functions as a positive regulator in the p53 pathway.
    Xu L; Hu J; Zhao Y; Hu J; Xiao J; Wang Y; Ma D; Chen Y
    Apoptosis; 2012 Nov; 17(11):1235-45. PubMed ID: 22914926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death.
    Bock FJ; Tanzer MC; Haschka MD; Krumschnabel G; Sohm B; Goetsch K; Kofler R; Villunger A
    Sci Rep; 2015 Jun; 5():11268. PubMed ID: 26062895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
    Benyamini H; Friedler A
    J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.
    Salvi M; Xu D; Chen Y; Cabrelle A; Sarno S; Pinna LA
    Biochem Biophys Res Commun; 2009 Sep; 387(3):606-10. PubMed ID: 19616514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A.
    Waters LC; Veverka V; Böhm M; Schmedt T; Choong PT; Muskett FW; Klempnauer KH; Carr MD
    Oncogene; 2007 Jul; 26(34):4941-50. PubMed ID: 17310995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 Tat.
    Gabizon R; Mor M; Rosenberg MM; Britan L; Hayouka Z; Kotler M; Shalev DE; Friedler A
    Biopolymers; 2008; 90(2):105-16. PubMed ID: 18189286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis.
    Cui X; Choi HK; Choi YS; Park SY; Sung GJ; Lee YH; Lee J; Jun WJ; Kim K; Choi KC; Yoon HG
    Cancer Lett; 2015 Feb; 357(1):307-315. PubMed ID: 25444898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
    Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
    Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis.
    Xu L; Chen Y; Song Q; Xu D; Wang Y; Ma D
    Neoplasia; 2009 Apr; 11(4):345-54. PubMed ID: 19308289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAF2 promotes TP53-mediated genotoxic stress response via stabilization of PDCD5.
    Park SY; Choi HK; Jo SH; Seo J; Han EJ; Choi KC; Jeong JW; Choi Y; Yoon HG
    Biochim Biophys Acta; 2015 May; 1853(5):1060-72. PubMed ID: 25603536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of S. cerevisiae PDCD5-like protein and its promoting role in H(2)O(2)-induced apoptosis in yeast.
    Hong J; Zhang J; Liu Z; Qin S; Wu J; Shi Y
    Biochemistry; 2009 Jul; 48(29):6824-34. PubMed ID: 19469552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress.
    Park SY; Choi HK; Choi Y; Kwak S; Choi KC; Yoon HG
    Cancer Lett; 2015 Feb; 357(1):419-427. PubMed ID: 25499082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.